Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896387 | PMC |
| http://dx.doi.org/10.4244/EIJ-D-21-00812L | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.
Int Urol Nephrol
October 2024
Consorcio Hospital General Universitario, Av. de les Tres Creus, 2, Valencia, Spain.
Purpose: Lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) is a growing condition in males associated with a high clinical, economic and humanistic burden. Several surgical techniques are available for the treatment of LUTS/BPH; thus, the aim of this study was to describe and explore the variability in the use of surgical procedures among Spanish hospitals.
Methods: The REVALURO was a retrospective, observational study conducted by collecting data from the clinical records of patients with LUTS/BPH aged ≥ 35 years, from 5 national reference hospitals, who were surgically treated between 2018 and 2022.
Commentary on "Age-stratified risk factors of re-intervention for uterine fibroids treated with high-intensity focused ultrasound".
Int J Gynaecol Obstet
July 2024
Department of Clinical Laboratory, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
Response: Age-stratified risk factors of re-intervention for uterine fibroids treated with high-intensity focused ultrasound.
Int J Gynaecol Obstet
July 2024
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, People's Republic of China.
Reintervention After TAVR vs SAVR: A Self-Expanding Experience.
JACC Cardiovasc Interv
April 2024
Department of Cardiology, Faculty of Medical and Health Sciences, Tel-Aviv Medical Center, Tel-Aviv University, Tel-Aviv, Israel.
Letter to the Editor Ross procedure valve function, clinical outcomes and predictors after 25 years follow up.
Curr Probl Cardiol
June 2024
Department of Cardiology, Reina Sofia University Hospital, Córdoba, Spain; Maimónides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV). Spain.
The following letter presents an answer of a comment of our work titled "Ross procedure: valve function, clinical outcomes and predictors after 25 years' follow-up," recently published in your journal by Rangwala et al. As our colleagues point out, the Ross procedure has excellent survival rates but a significant risk of valve dysfunction and therefore reintervention at follow-up. Although the survival advantage with the Ross procedure appears to be consistent compared with mechanical valve substitutes, this benefit is not as clear compared with biological valve substitutes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!